Perrigo Co PLC (PRGO)

PRGO (NYSE:Drugs) EQUITY
$194.50
neg -1.13
-0.58%
Today's Range: 193.60 - 196.37 | PRGO Avg Daily Volume: 2,070,100
Last Update: 05/27/15 - 4:03 PM EDT
Volume: 1,011,348
YTD Performance: 17.10%
Open: $195.79
Previous Close: $195.63
52 Week Range: $134.89 - $215.73
Oustanding Shares: 146,262,983
Market Cap: 29,028,814,236
6-Month Chart
TheStreet Ratings Grade for PRGO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 8 11 10
Moderate Buy 0 1 2 2
Hold 6 5 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.09 1.79 1.25 1.27
Latest Dividend: 0.12
Latest Dividend Yield: 0.25%
Dividend Ex-Date: 05/27/15
Price Earnings Ratio: 122.51
Price Earnings Comparisons:
PRGO Sector Avg. S&P 500
122.51 119.90 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
26.09% 41.20% 90.05%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.70 0.47 0.14
Net Income -53.50 -0.40 -0.15
EPS -62.20 -0.51 -0.21
Earnings for PRGO:
EBITDA 0.98B
Revenue 4.06B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (06/15) FY (06/16)
Average Estimate $2.03 $1.80 $7.33 $8.59
Number of Analysts 10 8 4 3
High Estimate $2.47 $1.98 $7.45 $8.74
Low Estimate $1.60 $1.65 $7.20 $8.34
Prior Year $1.74 $1.40 $6.39 $7.33
Growth Rate (Year over Year) 16.61% 28.57% 14.67% 17.28%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Antonia Oprita

 | Apr 22, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

David Peltier

 | Apr 21, 2015 | 4:49 PM EDT

U.S. stocks were mixed on Tuesday.

By

Jim Cramer

 | Apr 21, 2015 | 3:44 PM EDT

Biotech companies are saying, "I do."

By

Jim Cramer

 | Apr 9, 2015 | 1:58 PM EDT

These companies are the hottest thing going.

By

Bret Jensen

 | Apr 9, 2015 | 11:00 AM EDT

Recent activity has heated up and is creating shareholder value.

By

Bryan Ashenberg

 | Apr 9, 2015 | 7:07 AM EDT

But rate jitters still persist in the U.S.

By

Antonia Oprita

 | Apr 9, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

David Peltier

 | Apr 8, 2015 | 4:40 PM EDT

The Fed minutes produced little fanfare.

Market recovers from yesterday's losses as investors go back into "risk on" mode. Concert ...
We added this name a few weeks back and now it is the talk of the buyout craze. No matter...
Intel (INTC)'s pattern off the March corrective low (29.31) exhibits bullish form, which "...
Thanks brotha appreciate the love! Keep an eye on $YUM -- funny feeling the Street could g...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.